GIANT CELL ARTERITIS

Clinical trials for GIANT CELL ARTERITIS explained in plain language.

Never miss a new study

Get alerted when new GIANT CELL ARTERITIS trials appear

Sign up with your email to follow new studies for GIANT CELL ARTERITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 10 Not yet recruiting 1 Not yet finished but already full! 3 Completed 5 Terminated 1

New combo therapy aims to tame rare artery disease

Disease control Terminated

This study tested whether adding anakinra (a drug that blocks inflammation) to standard steroid treatment could lower relapse rates in people with giant cell arteritis, a disease that causes swollen arteries. About 30 adults aged 50 and older were enrolled, but the trial was stop…

Matched conditions: GIANT CELL ARTERITIS

Phase: PHASE3 • Sponsor: University Hospital, Caen • Aim: Disease control

Last updated May 13, 2026 16:00 UTC

GIANT CELL ARTERITIS

Get alerted when new GIANT CELL ARTERITIS trials appear

New combo therapy aims to tame rare artery disease